Cargando…
A chronic bioluminescent model of experimental visceral leishmaniasis for accelerating drug discovery
BACKGROUND: Visceral leishmaniasis is a neglected parasitic disease with no vaccine available and its pharmacological treatment is reduced to a limited number of unsafe drugs. The scarce readiness of new antileishmanial drugs is even more alarming when relapses appear or the occurrence of hard-to-tr...
Autores principales: | Álvarez-Velilla, Raquel, Gutiérrez-Corbo, Maria del Camino, Punzón, Carmen, Pérez-Pertejo, Maria Yolanda, Balaña-Fouce, Rafael, Fresno, Manuel, Reguera, Rosa María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392311/ https://www.ncbi.nlm.nih.gov/pubmed/30763330 http://dx.doi.org/10.1371/journal.pntd.0007133 |
Ejemplares similares
-
Infrared Fluorescent Imaging as a Potent Tool for In Vitro, Ex Vivo and In Vivo Models of Visceral Leishmaniasis
por: Calvo-Álvarez, Estefanía, et al.
Publicado: (2015) -
Topoisomerase IB poisons induce histone H2A phosphorylation as a response to DNA damage in Leishmania infantum
por: Gutiérrez-Corbo, Camino, et al.
Publicado: (2019) -
Antiparasitic effect of synthetic aromathecins on Leishmania infantum
por: Reguera, Rosa M., et al.
Publicado: (2019) -
Axenic interspecies and intraclonal hybrid formation in Leishmania: Successful crossings between visceral and cutaneous strains
por: Gutiérrez-Corbo, Camino, et al.
Publicado: (2022) -
Miltefosine and Nifuratel Combination: A Promising Therapy for the Treatment of Leishmania donovani Visceral Leishmaniasis
por: Melcon-Fernandez, Estela, et al.
Publicado: (2023)